BrainsWay Ltd (BWAY) - Total Stockholders' Equity

The BrainsWay Ltd. (BWAY) price chart illustrates the dynamics of a company that mitigates risks by developing brain stimulation systems to combat addiction and depression, generating revenue through hardware sales and maintenance. The current metric stands at 0.08. Physicians value the business for the effectiveness of the Deep TMS method. Meanwhile, design remains an internal process, while parts manufacturing is outsourced to trusted factories.

Book value capitalization is calculated as the difference between the issuer's total assets and all liabilities. This metric determines the real value of equity, serving as an indicator of financial stability and protection against default. For BrainsWay Ltd. (BWAY), steady demand for TMS therapy ensures the predictability of net assets regardless of economic cycles. By analyzing the company's book capitalization chart, an investor assesses the preservation of funds. Growth in this indicator confirms the capitalization of the business.